InMode (INMD) Liabilities and Shareholders Equity (2018 - 2026)

InMode's (INMD) quarterly Liabilities and Shareholders Equity came in at $750.8 million in Q1 2026, up 6.54% year-on-year from $704.7 million in Q1 2025, and down 2.03% quarter-over-quarter from $766.4 million in Q4 2025.

InMode (INMD) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends

InMode has disclosed Liabilities and Shareholders Equity across 9 years of filings, most recently posting $750.8 million for Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $750.8 million, up 6.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.0 billion (down 6.74% YoY), and the FY2025 annual result was $766.4 million, down 2.45% from the prior year.
  • Liabilities and Shareholders Equity came in at $750.8 million for Q1 2026 at InMode, down from $766.4 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $891.7 million in Q1 2024 to a low of $464.5 million in Q1 2022.
  • The 5-year median for Liabilities and Shareholders Equity is $734.6 million (2025), against an average of $723.4 million.
  • Across the five-year window, Liabilities and Shareholders Equity jumped 44.17% in 2023 and dropped 20.97% in 2025, its largest moves.
  • InMode's Liabilities and Shareholders Equity stood at $644.4 million in 2022, then jumped by 33.97% to $863.3 million in 2023, then dropped by 8.99% to $785.7 million in 2024, then declined by 2.45% to $766.4 million in 2025, then fell by 2.03% to $750.8 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $750.8 million (Q1 2026), $766.4 million (Q4 2025), and $734.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 110.43 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 46.29 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 37.13 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 10.74 Bn
10 InMode 3.35 -388.37 Mn 61.55 Mn 750.84 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 750.84 Mn
Dec 31, 2025 766.43 Mn
Sep 30, 2025 734.61 Mn
Jun 30, 2025 708.35 Mn
Mar 31, 2025 704.74 Mn
Dec 31, 2024 785.67 Mn
Sep 30, 2024 824.03 Mn
Jun 30, 2024 859.84 Mn
Mar 31, 2024 891.74 Mn
Dec 31, 2023 863.29 Mn
Sep 30, 2023 793.53 Mn
Jun 30, 2023 734.08 Mn
Mar 31, 2023 669.61 Mn
Dec 31, 2022 644.41 Mn
Sep 30, 2022 578.98 Mn
Jun 30, 2022 523.21 Mn
Mar 31, 2022 464.47 Mn
Dec 31, 2021 478.54 Mn
Sep 30, 2021 447.66 Mn
Jun 30, 2021 383.03 Mn